Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

Delayed Quote. Delayed  - 08/30 10:00:00 pm
104.305 USD   +0.87%
08/15 LIGAND PHARMACE : Results from Phase 1 Trials with Ligand’s LG..
08/04 LIGAND PHARMACE : reports 2Q loss
08/04 LIGAND PHARMACE : Reports Second Quarter 2016 Financial Results
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 06:55pm CEST

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LIGAND PHARMACEUTICALS INC
08/26 LIGAND PHARMACEUTICALS INC : Changes in Registrant's Certifying Accountant, Fina..
08/25 LIGAND PHARMACEUTICALS : Results from Phase 1 Trials with Ligand's LGD-6972 in T..
08/15 LIGAND PHARMACEUTICALS : Results from Phase 1 Trials with Ligand’s LGD-697..
08/04 LIGAND PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
08/04 LIGAND PHARMACEUTICALS INC : Results of Operations and Financial Condition (form..
08/04 LIGAND PHARMACEUTICALS : reports 2Q loss
08/04 LIGAND PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results
07/29 LIGAND PHARMACEUTICALS INC : Other Events (form 8-K)
07/29 LIGAND PHARMACEUTICALS : Announces Multi-Program LTP Technology Licensing Agreem..
07/15 BLACKROCK INSTITUTIONAL TRUST COMPAN : Boosts Stake in Ligand Pharmaceuticals In..
More news
Sector news : Biotechnology & Medical Research - NEC
08/29DJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/07 WEEK IN REVIEW : China Life Science Goes International For Deals
08/05 17 Stocks For August 2016
08/04 Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q2 2016 Results - Earnings..
08/04 Ligand Pharmaceuticals beats by $0.10, beats on revenue
08/03 Notable earnings before Thursday?s open